Displaying 1 - 20 of 26
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
40 66721 CATAFLAM 1.8MG/ML SUSP (NVS/COL) DICLOFENAC P DICLOFENAC POTASSIUM CATAFLAM 120ML C 8.75 0.07 SUSPENSION 0 ML NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 66721 CATAFLAM 1.8MG/ML SUSP (NVS) DICLOFENAC (C) DICLOFENAC POTASSIUM CATAFLAM 120ML C 9.62 0.0802 ML 120 BOTT NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2025-01-20 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-12-09
41 66725 DICLOFENAC POTASSIUM 1.8MG/ML SUSP (KWA) (C) DICLOFENAC POTASSIUM DICLOFENAC POTASSIUM 120ML C 4.81 0.0401 ML 120 BOTT KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
40 66731 CATAFLAM 25MG TAB (NVS/COL) DICLOFENAC POTASS DICLOFENAC POTASSIUM CATAFLAM 20'S A 8.86 0.44 TABLET 15 TAB NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 66731 CATAFLAM 25MG TAB (NVS) DICLOFENAC POTAS DICLOFENAC POTASSIUM CATAFLAM 20'S A 8.86 0.4431 TAB 15 BOX NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
42 66731 CATAFLAM 25MG TAB (NVS) DICLOFENAC POTAS DICLOFENAC POTASSIUM CATAFLAM 20'S A 8.86 0.44 TAB 15 BLIS NVS NOVARTIS CARIBE SA COL AVENTA BARBADOS 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
40 66739 CATAFLAM DISPERS 50MG TAB (NVS/COL) DICLOFENA DICLOFENAC POTASSIUM CATAFLAM DISPERS 12'S C 12.07 1.01 TABLET 0 TAB NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 66739 CATAFLAM DISPERS 50MG TAB (NVS) DICLOFEN (C) DICLOFENAC POTASSIUM CATAFLAM DISPERS 12'S C 12.07 1.0058 TAB 15 BOX NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
42 66739 CATAFLAM DISPERS 50MG TAB (NVS) DICLOFEN DICLOFENAC POTASSIUM CATAFLAM DISPERS 12'S C 12.07 1.01 TAB 15 BLIS NVS NOVARTIS CARIBE SA COL AVENTA BARBADOS 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
40 6673AB CATAFLAM SOFT GEL 50MG CAP (NVS/COL) DICLOFEN DICLOFENAC POTASSIUM CATAFLAM SOFT GEL 50'S C 46.81 0.94 CAPSULE 0 CAP NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 6673AB CATAFLAM SOFT GEL 50MG CAP (NVS) DICLOFE (C) DICLOFENAC POTASSIUM CATAFLAM SOFT GEL 50'S C 46.81 0.9362 CAP 0 BOX NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
42 6673AB CATAFLAM SOFT GEL 50MG CAP (NVS) DICLOFE DICLOFENAC POTASSIUM CATAFLAM SOFT GEL 50'S C 46.81 0.94 CAP 0 BLIS NVS NOVARTIS CARIBE SA COL AVENTA BARBADOS 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
40 6673AE DICLO-K 50MG TAB (RYV/ALW) DICLOFENAC POTASSI DICLOFENAC POTASSIUM DICLO-K 100'S A 2.69 0.03 TABLET 15 TAB RYV RYVIS PHARMA PVT. LTD ALW ALTIMAR WHOLESALERS INC 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
41 6673AE DICLO-K 50MG TAB (RYV) DICLOFENAC POTASS DICLOFENAC POTASSIUM DICLO-K 100'S A 4.05 0.0405 TAB 15 BOX RYV RYVIS PHARMA PVT. LTD ALW ALTIMAR WHOLESALERS INC 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
41 6673AN DICLOFENAC POTASSIUM 50MG TAB (HEA) DICLOFENAC POTASSIUM DICLOFENAC POTASSIUM 2X10 A 1.41 0.0707 TAB 15 BOX HEA HEALTH 2000 INC ATB ANSA TRADING BARBADOS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
41 6673AP DICLOFENAC POTASSIUM 50MG TAB (MCP) DICLOFENAC POTASSIUM DICLOFENAC 10X10 A 3.48 0.0348 TAB 15 BOX MCP MACLEODS PHARMACEUTICALS LTD AHI ARMSTRONG HEALTHCARE INC 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
42 6673AT DICLOFENAC POTASSIUM 50MG TAB (ZYP) DICLOFENAC POTASSIUM DICLOFENAC POTASSIUM 10X10 A 2.94 0.03 TAB 15 BLIS ZYP ZYPHAR'S PHARMACEUTICAL Pvt Ltd RXP RX PRO INC 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
42 6673AY DICLOFENAC POTASSIUM 50MG TAB (HEA) DICLOFENAC POTASSIUM DICLOFENAC POTASSIUM 2X10 C 1.33 0.07 TAB 15 BLIS HEA HEALTH 2000 INC AHI ARMSTRONG HEALTHCARE INC 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 Price Change ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2025-10-31
42 6673AZ DICLOFENAC POTASSIUM 50MG TAB (HEA) DICLOFENAC POTASSIUM DICLOFENAC 2X10 C 1.33 0.07 TAB 15 BLIS HEA HEALTH 2000 INC CWS CAPSULE WHOLESALE 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 Add to Contract as Cat C ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-01-26
42 6673BA DICLOFENAC POTASSIUM 50MG TAB (HEA) © DICLOFENAC POTASSIUM DICLOFENAC POTASSIUM 2X10 C 1.33 0.07 TAB 15 HEA HEALTH 2000 INC STO BRYDEN STOKES LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 Add to Contract as Cat C ORAL 0 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-02-27